You have 9 free searches left this month | for more free features.

Parotid Neoplasms

Showing 26 - 50 of 756

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Xerostomia Due to Radiotherapy, Hyposalivation, Xerostomia Trial in Copenhagen (Allogeneic adipose derived stem/stromal cells)

Active, not recruiting
  • Xerostomia Due to Radiotherapy
  • +8 more
  • Allogeneic adipose derived stem/stromal cells
  • Copenhagen, Denmark
  • +1 more
Jan 27, 2021

Head Neck Cancer, Head and Neck Tumors, Xerostomia Trial in Granada (Energy density photobiomodulation (7.5), Sham )

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Energy density photobiomodulation (7.5)
  • Sham placebo
  • Granada, Spain
    Faculty of Health Sciences
Nov 6, 2022

Head and Neck Cancer:Retrospective Analysis

Completed
  • Head and Neck Cancer
  • +2 more
  • multiparametric MRI
  • (no location specified)
Feb 23, 2022

Head Neck Cancer, Multiparametric MRI, Cervical Lymph Node Trial in Bruges

Active, not recruiting
  • Head and Neck Cancer
  • +5 more
    • Bruges, Belgium
      Division of Maxillofacial Surgery, Department of Surgery, AZ Sin
    Feb 23, 2022

    AAV2hAQP1 for Radiation Induced Xerostomia

    Enrolling by invitation
    • Radiation-induced Xerostomia
      • Stanford, California
      • +3 more
      Dec 22, 2022

      The Myeloid Neoplasms Biology and Outcome Project

      Recruiting
      • Myeloid Neoplasm
        • Heidelberg, Baden-Württemberg, Germany
          UHHeidelberg
        Nov 21, 2022

        True Exocrine Epithelial Pancreatic Cystic Neoplasms Based on

        Completed
        • Pancreas Cancer
        • surgical resection
        • (no location specified)
        Apr 22, 2022

        Head Neck Cancer Trial in Rochester (Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS))

        Recruiting
        • Head and Neck Cancer
        • Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS)
        • Rochester, New York
          University of Rochester
        Jun 7, 2022

        Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

        Recruiting
        • Digestive System Neoplasms
        • iNeo-Vac-R01
        • Hangzhou, Zhejiang, China
          Department of General Surgery, Institute of Minimally Invasive S
        Sep 8, 2023

        Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

        Recruiting
        • Neoplasms
        • Muscle Neoplasm
        • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
        • Rome, Italy
          "Regina Elena" National Cancer Institute
        Jun 15, 2023

        Endoscopic Mucosal Resection With Circumferential Incision Trial in Moscow (Endoscopic mucosal resection with circumferential

        Active, not recruiting
        • Endoscopic Mucosal Resection With Circumferential Incision
        • Endoscopic mucosal resection with circumferential incision
        • Endoscopic submucosal dissection
        • Moscow, Russian Federation
          Elmira
        Jan 10, 2023

        Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

        Not yet recruiting
        • Biliary Tract Neoplasms
        • Total Neoadjuvant Treatment
        • (no location specified)
        Sep 7, 2023

        MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

        Recruiting
        • MDS/MPN
        • Azacitidine (AZA) with Ruxolitinib
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital of Nanjing Medical University
        Apr 17, 2023

        Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)

        Recruiting
        • Squamous Cell Head and Neck Cancer
        • +2 more
        • AAV2hAQP1
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        May 3, 2022

        Epidemiological and Clinical-pathological Factors of

        Completed
        • Myeloproliferative Neoplasm
        • +4 more
          • Guayaquil, Guayas, Ecuador
            Sociedad de Lucha Contra el Cáncer
          Apr 25, 2023

          Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

          Recruiting
          • Digestive System Neoplasms
          • iNeo-Vac-R01 in combination with standard adjuvant therapy
          • Hangzhou, Zhejiang, China
            Department of General Surgery, Institute of Minimally Invasive S
          Sep 8, 2023

          Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

          Recruiting
          • Digestive System Neoplasms
          • iNeo-Vac-R01
          • Hangzhou, Zhejiang, China
            Department of General Surgery, Institute of Minimally Invasive S
          Sep 8, 2023

          Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

          Recruiting
          • Myeloproliferative Neoplasms
          • Birmingham, Alabama
          • +16 more
          Jan 27, 2023

          CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

          Recruiting
          • CD70-positive Advanced Urologic Neoplasms
          • Anti-CD70 CAR-T cells
          • Shanghai, Shanghai, China
            Changhai Hospital
          Aug 11, 2023

          Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)

          Recruiting
          • Head and Neck Cancer
          • Submandibular Gland Stem Cell Transplantation
          • Groningen, Netherlands
            UMCG
          May 24, 2022

          Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

          Active, not recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Orange, California
            Chao Family Comprehensive Cancer Center, University of Californi
          Jan 6, 2023

          GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

          Enrolling by invitation
          • GEP-NET
          • +3 more
          • Copenhagen, Denmark
            Rigshospitalet
          Jan 24, 2023

          Myeloproliferative Tumors Trial (INCA033989)

          Not yet recruiting
          • Myeloproliferative Neoplasms
          • (no location specified)
          Sep 11, 2023

          Myeloid Tumor Trial in Memphis (CPX-351, MHA)

          Recruiting
          • Myeloid Neoplasm
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Jan 20, 2023

          TEXTBOOK OUTCOME IN ADRENAL NEOPLASMS

          Completed
          • Outcome Assessment
          • Adrenal Neoplasm
          • Adrenalectomy
          • Alicante, Spain
            Juan Jesús Rubio García
          May 24, 2023